A method for large-scale production of extracellular vesicles enriched with specific microRNAs (miRNAs) has been developed, offering a manufacturing standardization process which may have therapeutic applications and clinical impact.
A Trojan horse delivery method for miRNA-enriched extracellular vesicles
